Stay updated on Nivolumab Combo vs Pemetrexed/Cisplatin in Mesothelioma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Combo vs Pemetrexed/Cisplatin in Mesothelioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Combo vs Pemetrexed/Cisplatin in Mesothelioma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The Study Details page now includes new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and shows recruitment is closed ('No longer looking for participants'). The revision version updated from v3.5.5 to v3.6.0 and the Intervention/Treatment heading formatting was adjusted.
    Difference
    0.2%
    Check dated 2026-06-15T18:02:40.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    Revision: v3.5.5 has been added and Revision: v3.5.4 has been removed, updating the page's revision tag. This change reflects a minor metadata update to the page rather than altering study content or user-facing information.
    Difference
    0.0%
    Check dated 2026-06-08T15:30:31.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.3 to v3.5.4, indicating a new build of the page. This update is a structural/metadata change and does not modify the study content or displayed information.
    Difference
    0.0%
    Check dated 2026-05-18T03:51:07.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page’s footer/site version marker changes from **Revision: v3.5.2** to **Revision: v3.5.3**, indicating an update to the ClinicalTrials.gov site release rather than the clinical study details.
    Difference
    0.0%
    Check dated 2026-04-26T15:16:48.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Collaborator name updated from Ono Pharmaceutical Co. Ltd to Ono Pharmaceutical Co., Ltd and the page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-19T12:49:08.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    A new publication citation (Five-Year Clinical Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy in CheckMate 743) was added to the Publications section. The page revision was updated to v3.5.0, and the Italy location listing was changed from Napoli to Naples (Naples 80131) to reflect naming in English.
    Difference
    0.1%
    Check dated 2026-03-21T09:17:17.000Z thumbnail image

Stay in the know with updates to Nivolumab Combo vs Pemetrexed/Cisplatin in Mesothelioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo vs Pemetrexed/Cisplatin in Mesothelioma Clinical Trial page.